Literature DB >> 6231289

Structure of thrombospondin.

J E Coligan, H S Slayter.   

Abstract

The NH2-terminal amino acid sequences of thrombospondin and of a 30,000-Da heparin-binding peptide derived from thrombospondin by treatment with plasmin are identical. The heparin-binding peptide is homogeneous in size but slightly heterogeneous in charge with the predominant isoelectric points being 6.1 and 5.7. Electron microscopy of tungsten replicas of thrombospondin reveals a tripartite structure resembling a "bola" which is about 60 nm across when fully extended. Each part of the molecule terminates in a globular node or head which disappears upon limited plasmin digestion, suggesting that the heparin-binding peptide is located in the head region. In addition to the heparin-binding peptide, a 20,000-Da peptide also apparently associated with the head region is liberated during proteolysis. The electron micrographs indicate that the legs of the bola-like structure must be folded into an extended, flexible, tertiary structure. These legs, each of about 65,000 Da, appear to be attached near the ends opposite the heads, probably by disulfide bonds. Each leg possesses a tab or protein (approximately 20,000 Da) which juts out from this attachment point.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231289

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Models of human platelet thrombospondin in solution. A dynamic light-scattering study.

Authors:  L Vuillard; P Clezardin; A Miller
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

2.  Ultrastructure and composition of bovine conglutinin.

Authors:  C J Strang; H S Slayter; P J Lachmann; A E Davis
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

3.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

Authors:  R A Majack; S C Cook; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Thrombospondin fragmentation by alpha-thrombin and resistance to gamma-thrombin.

Authors:  K Takahashi; M Aiken; J W Fenton; D A Walz
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

5.  A monoclonal antibody against human thrombospondin inhibits platelet aggregation.

Authors:  V M Dixit; D M Haverstick; K M O'Rourke; S W Hennessy; G A Grant; S A Santoro; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Cartilage oligomeric matrix protein-deficient mice have normal skeletal development.

Authors:  Liz Svensson; Attila Aszódi; Dick Heinegård; Ernst B Hunziker; Finn P Reinholt; Reinhard Fässler; Ake Oldberg
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin.

Authors:  V M Dixit; S W Hennessy; G A Grant; P Rotwein; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Isolation of the thrombospondin membrane receptor.

Authors:  A S Asch; J Barnwell; R L Silverstein; R L Nachman
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Extracellular matrix proteins and tumor angiogenesis.

Authors:  N E Campbell; L Kellenberger; J Greenaway; R A Moorehead; N M Linnerth-Petrik; J Petrik
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

10.  Interactions among stalk modules of thrombospondin-1.

Authors:  Yuanyuan Liu; Deane F Mosher
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.